InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -61.16% |
| Q3 2025 | 29.11% |
| Q2 2025 | -14.85% |
| Q1 2025 | 17.63% |
| Q4 2024 | -53.47% |
| Q3 2024 | 13.41% |
| Q2 2024 | -12.47% |
| Q1 2024 | -16.55% |
| Q4 2023 | 41.73% |
| Q3 2023 | -465.91% |
| Q2 2023 | 77.56% |
| Q1 2023 | 29.77% |
| Q4 2022 | 41.32% |
| Q3 2022 | 38.40% |
| Q2 2022 | -126.43% |
| Q1 2022 | 35.82% |
| Q4 2021 | -82.25% |
| Q3 2021 | 8.81% |
| Q2 2021 | -5.07% |
| Q1 2021 | -38.23% |
| Q4 2020 | -40.32% |
| Q3 2020 | 27.12% |
| Q2 2020 | -8.41% |
| Q1 2020 | 18.83% |
| Q4 2019 | 11.12% |
| Q3 2019 | 16.69% |
| Q2 2019 | -28.80% |
| Q1 2019 | -34.19% |
| Q4 2018 | 11.41% |
| Q3 2018 | 1.22% |
| Q2 2018 | -35.11% |
| Q1 2018 | -34.24% |
| Q4 2017 | 16.34% |
| Q3 2017 | 1.64% |
| Q2 2017 | -60.30% |
| Q1 2017 | -33.17% |
| Q4 2016 | -119.78% |
| Q3 2016 | 19.47% |
| Q2 2016 | -34.00% |
| Q1 2016 | 47.25% |